Literature DB >> 12629078

Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study.

Thor Ueland1, Kim Brixen, Lis Mosekilde, Leif Mosekilde, Allan Flyvbjerg, Jens Bollerslev.   

Abstract

Serum GH and IGF-I levels decline with increasing age, whereas osteoprotegerin (OPG) increases. IGFs as well as OPG are present in bone matrix and mediate the effects of many upstream hormones (e.g. estrogen). To evaluate whether changes in these proteins may to some extent explain the decrease in bone mass in postmenopausal or senile osteoporosis, we measured bone contents of IGF-I, IGF-II, IGF binding protein (IGFBP)-3, IGFBP-5, and OPG in combined extracts obtained after EDTA and guanidine hydrochloride extraction in 60 postmenopausal women aged 47-74 (mean, 63) yr with a previous distal forearm fracture and a hip or spine Z-score less than 0. We found age-related increases in IGFBP-3 (r = 0.35; P < 0.01), IGFBP-5 (r = 0.59; P < 0.001), and OPG (r = 0.36; P < 0.01) in cortical bone, significantly inversely correlated with femoral neck and lumbar spine BMD. A correlation between age and OPG was also detected in trabecular bone (r = 0.27; P < 0.05). A pronounced age-related decrease in cortical calcium contents (r = -0.60; P < 0.001), positively correlated with femoral neck and lumbar spine BMD, was also found. No age-related changes were detected for IGF-I or IGF-II. The present study demonstrates age-related changes in cortical bone contents of IGFBPs, calcium, and OPG, possibly related to the pathophysiology of postmenopausal osteoporosis. As for OPG, our findings probably represent compensatory responses to increased osteoclastic resorption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629078     DOI: 10.1210/jc.2002-020977

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Osteoclasts prefer aged bone.

Authors:  K Henriksen; D J Leeming; I Byrjalsen; R H Nielsen; M G Sorensen; M H Dziegiel; T John Martin; C Christiansen; P Qvist; M A Karsdal
Journal:  Osteoporos Int       Date:  2007-01-10       Impact factor: 4.507

2.  Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis.

Authors:  Saba Abdi; Rawan A Binbaz; Abdul Khader Mohammed; Mohammed G A Ansari; Kaiser Wani; Osama E Amer; Abdullah M Alnaami; Naji Aljohani; Nasser M Al-Daghri
Journal:  Genes (Basel)       Date:  2021-01-29       Impact factor: 4.096

3.  Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate.

Authors:  Behnam Eslami; Shuanhu Zhou; Inge Van Eekeren; Meryl S LeBoff; Julie Glowacki
Journal:  Calcif Tissue Int       Date:  2011-02-15       Impact factor: 4.333

4.  Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha.

Authors:  P Olesen; T Ledet; L M Rasmussen
Journal:  Diabetologia       Date:  2005-02-08       Impact factor: 10.122

5.  Serum markers of bone turnover in dialyzed patients separated according to age.

Authors:  Alicja E Grzegorzewska; Monika Młot
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

6.  Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study.

Authors:  L Jørgensen; A Vik; N Emaus; J Brox; J-B Hansen; E Mathiesen; P Vestergaard
Journal:  Osteoporos Int       Date:  2009-08-22       Impact factor: 4.507

7.  Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.

Authors:  Eva Grimaud; Luc Soubigou; Séverine Couillaud; Patrick Coipeau; Anne Moreau; Norbert Passuti; François Gouin; Françoise Redini; Dominique Heymann
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 8.  Insulin- like Growth Factor-Binding Protein Action in Bone Tissue: A Key Role for Pregnancy- Associated Plasma Protein-A.

Authors:  James Beattie; Hasanain Al-Khafaji; Pernille R Noer; Hanaa Esa Alkharobi; Aishah Alhodhodi; Josephine Meade; Reem El-Gendy; Claus Oxvig
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-16       Impact factor: 5.555

9.  Human decellularized bone scaffolds from aged donors show improved osteoinductive capacity compared to young donor bone.

Authors:  Christopher A Smith; Tim N Board; Paul Rooney; Mark J Eagle; Stephen M Richardson; Judith A Hoyland
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

10.  Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis.

Authors:  Thor Ueland; Lis Stilgren; Jens Bollerslev
Journal:  Int J Mol Sci       Date:  2019-06-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.